Skip to main content

Jimini Health

Category: AI in Healthcare

An AI-powered behavioral health platform that augments traditional therapy with continuous AI support between sessions through Sage, a clinically supervised AI assistant that works as part of the care team. Jimini Health was founded in 2023. The company is led by Luis Voloch. Based in New York, United States. Team size: 20-25. Total funding raised: $25.0M. Latest round: Seed ($17.0M, Mar 2026). Key investors include M13, Zetta Venture Partners, LionBird, Town Hall Ventures, OneMind.

Founded
2023
Headquarters
New York, United States
Team size
20-25
Total funding
$25.0M

Value proposition

Bridges the critical gap between therapy sessions by providing continuous, evidence-based AI support while maintaining full clinician oversight—enabling care adherence and clinical outcomes previously unattainable with traditional weekly therapy alone.

Products and solutions

Sage AI Behavioral Health Assistant (24/7 patient support), Clinician Dashboard with Full Interaction Visibility, AI-Powered Patient Intake System, Continuous Messaging-Based Therapy Support, Personalized Exercise and Skills Practice Platform, Measurement-Based Care Tracking, Technical Blueprint for Safe Patient-Facing AI

Unique value

Purpose-built, clinician-supervised AI that augments rather than replaces human therapists. Sage operates as a care team member with all patient interactions visible to supervising clinicians. Diagnostics and care decisions remain exclusively with human clinical team. The company operates its own clinic to validate safety and efficacy.

Target customer

Large behavioral health provider organizations, health systems, and patients with complex mental health needs including depression, OCD, and various neurological disorders

Industries served

Behavioral Health, Mental Healthcare, Digital Health, Healthcare Technology, Teletherapy, AI Healthcare

Technology advantage

Combines evidence-based therapeutic modalities (CBT, DBT, trauma-informed care) with proprietary AI trained by world-leading psychologists from Stanford, Harvard, Yale, and Dartmouth. Features include continuous care model, measurement-based care, clinical escalation protocols, and published technical blueprint for AI safety in behavioral health settings. The platform maintains HIPAA compliance while providing 24/7 support between sessions.

How they differentiate

Jimini Health uniquely combines clinician-supervised AI (Sage) with full transparency and clinical oversight, where all patient-AI interactions are visible to supervising clinicians and care decisions remain exclusively with human providers. Unlike standalone AI chatbots, Jimini operates as a care team member that augments rather than replaces therapists, operates its own clinic to validate safety, and targets enterprise behavioral health organizations rather than direct-to-consumer.

Main competitors

Woebot Health, Wysa, Spring Health

Key partnerships

Stanford University (Chief Scientist Dr. Johannes Eichstaedt), Dartmouth College (Chief Clinical Officer Dr. Bill Hudenko), Harvard Medical School (Dr. Sabine Wilhelm, Professor of Psychology), Yale University (Dr. Seth Feuerstein, Advisory Board), Google DeepMind (Dr. Pushmeet Kohli, VP of Science, Advisor), MIT (Dr. Robert Langer, Institute Professor, Advisor), Oracle Health (David Feinberg, Chairman, Advisor), Boston University (Dr. Nikolaos Daskalakis, Professor, Advisor), University of Washington (Dr. Tim Althoff, Professor, Advisor), Andy Slavitt (former CMS Acting Administrator, Investor/Advisor), Large Behavioral Health Provider Organizations (early adopter partnerships in development)

Notable customers

Large behavioral health provider organizations (unnamed), Health systems seeking AI integration

Major milestones

Launched with $8M pre-seed funding in November 2024, Raised $17M seed funding led by M13 in March 2026, Operates own clinic to validate AI safety and efficacy, Published technical blueprint for safe patient-facing AI in behavioral health, Established partnerships with academic institutions (Stanford, Harvard, Yale, Dartmouth, MIT, BU, UW), Robert Langer (Moderna co-founder) joined advisory board, Andy Slavitt (former CMS Acting Administrator) joined as investor/advisor

Growth metrics

Raised $25M+ total funding across two rounds; actively partnering with largest behavioral health provider organizations in the country; expanding team with forward deployed engineers, ML engineers, and business development roles

Market positioning

Enterprise B2B platform targeting large behavioral health provider organizations and health systems, positioned as clinical-grade AI infrastructure that integrates into existing care models with regulatory compliance (HIPAA, CMS frameworks)

Geographic focus

United States

Patents and IP

No registered patents publicly disclosed as of current date

About Luis Voloch

Luis Voloch is a seasoned entrepreneur with extensive experience in AI and healthcare technology. He co-founded and served as CTO of Immunai, an AI-driven cancer immunotherapy company valued at over $1 billion that has raised more than $600M since 2018. He previously worked as a Forward Deployed Engineer at Palantir Technologies (2015-2018) and served as a Lecturer at Stanford University Graduate School of Business (2022-2024). He holds degrees from MIT (BS in Mathematics & Computer Science, MS in Electrical Engineering & Computer Science).

Official website: